pramipexole   Click here for help

GtoPdb Ligand ID: 953

Synonyms: Mirapex® | Mirapexin® | Sifrol® | SND-919CL2Y | U-98528E
Approved drug PDB Ligand
pramipexole is an approved drug (FDA and EMA (1997))
Compound class: Synthetic organic
Comment: Marketed formulations may contain pramipexole dihydrochloride monohydrate (PubChem CID 166589).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: pramipexole

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 79.18
Molecular weight 211.11
XLogP 0.4
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCNC1CCc2c(C1)sc(n2)N
Isomeric SMILES CCCN[C@H]1CCc2c(C1)sc(n2)N
InChI InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1
InChI Key FASDKYOPVNHBLU-ZETCQYMHSA-N
No information available.
Summary of Clinical Use Click here for help
Used in the treatment of idiopathic Parkinson's disease.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
The exact mechanism of action of pramipexole is unknown but its effects in the treatment of Parkinson's disease are believed to be due to its stimulation of dopamine receptors in the brain.
External links Click here for help